Localizing matrix metalloproteinase activities in the pericellular environment

FEBS Journal

Volumn 278, Issue 1, 2011, Pages 2-15

  Murphy, Gillian ^a   Nagase, Hideaki ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CD44; collagen; extracellular matrix; integrin; proteoglycan; receptor; tetraspanin

Indexed keywords

AGGRECANASE 1; ALPHA INTEGRIN; ALPHAVBETA8 INTEGRIN; CD147 ANTIGEN; CD44V ANTIGEN; CD63 ANTIGEN; CHOLESTEROL SULFATE; COLLAGENASE 3; ENDO180; GELATINASE A; GELATINASE B; HERMES ANTIGEN; LECTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MEMBRANE TYPE 5 MATRIX METALLOPROTEINASE; MEMBRANE TYPE 6 MATRIX METALLOPROTEINASE; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VITRONECTIN RECEPTOR;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL ANCHORAGE; CELL INVASION; CELL SURFACE; COLLAGEN DEGRADATION; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; INTERNALIZATION; MEMBRANE BINDING; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ANALYSIS; TISSUE REPAIR; WOUND HEALING;

CELL MEMBRANE; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES;

EID: 78650440475     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07918.x     Document Type: Review

References (109)

1. Gialeli C, Theocharis AD, &, Karamanos NK, (2010) Metalloproteinases in health and disease: roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278, 16-27.
2. Murphy G, &, Nagase H, (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29, 290-308.
3. Hadler- Olsen EFB, Sylte I, Uhlin-Hansen L, &, Winberg J-O, (2010) Metalloproteinases in health and disease: regulation of matrix metalloproteinase activity. FEBS J 278, 28-45.
4. Ra HJ, &, Parks WC, (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol 26, 587-596.
5. Nagase H, Visse R, &, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69, 562-573.
6. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD, et al. (1995) Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 4, 1966-1976.
7. Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, &, Tryggvason K, (1999) Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284, 1667-1670.
8. Elkins PA, Ho YS, Smith WW, Janson CA, D'Alessio KJ, McQueney MS, Cummings MD, &, Romanic AM, (2002) Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. Acta Crystallogr D Biol Crystallogr 58, 1182-1192.
9. Jozic D, Bourenkov G, Lim NH, Visse R, Nagase H, Bode W, &, Maskos K, (2005) X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding. J Biol Chem 280, 9578-9585.
10. Van Wart HE, &, Birkedal-Hansen H, (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87, 5578-5582.
11. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, &, Docherty AJP, (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269, 6632-6636.
12. Shipley JM, Doyle GAR, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG, &, Senior RM, (1996) The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. J Biol Chem 271, 4335-4341.
13. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, &, Overall CM, (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
14. Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, &, Nagase H, (2004) Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 23, 3020-3030.
15. Sela-Passwell N, Rosenblum G, Shoham T, &, Sagi I, (2010) Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? Biochim Biophys Acta 1803, 29-38.
16. Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, &, Fridman R, (2008) MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev 27, 289-302.
17. Zucker S, Pei D, Cao J, &, Lõpez-Otín C, (2003) Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54, 1-74.
18. Itoh Y, &, Seiki M, (2006) MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206, 1-8.
19. Barbolina MV, &, Stack MS, (2008) Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin Cell Dev Biol 19, 24-33.
20. Knäuper V, Bailey L, Worley JR, Soloway P, Patterson ML, &, Murphy G, (2002) Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett 532, 127-130.
21. Itoh Y, Ito N, Nagase H, Evans RD, Bird SA, &, Seiki M, (2006) Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol Biol Cell 17, 5390-5399.
22. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, &, Sato H, (2001) Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 276, 28204-28211.
23. Sato H, Okada Y, &, Seiki M, (1997) Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 78, 497-500.
24. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, &, Seiki M, (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20, 4782-4793.
25. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, &, Seiki M, (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21, 3949-3959.
26. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, &, Mueller SC, (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66, 3034-3043.
27. Poincloux R, Lizarraga F, &, Chavrier P, (2009) Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci 122, 3015-3024.
28. Clark ES, &, Weaver AM, (2008). A new role for cortactin in invadopodia: regulation of protease secretion. Eur J Cell Biol.
29. Bravo-Cordero JJ, Marrero-Diaz R, Megías D, Genís L, García-Grande A, García MA, Arroyo AG, &, Montoya MC, (2007) MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J 26, 1499-1510.
30. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B, &, Béliveau R, (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507, 231-236.
31. Langlois S, Gingras D, &, Béliveau R, (2004) Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 103, 3020-3028.
32. Lehti K, Valtanen H, Wickström S, Lohi J, &, Keski-Oja J, (2000) Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275, 15006-15013.
33. Sakamoto T, &, Seiki M, (2009). Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity. Genes Cells 14, 617-626.
34. Li XY, Ota I, Yana I, Sabeh F, &, Weiss SJ, (2008) Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol Biol Cell 19, 3221-3233.
35. Hotary K, Allen E, Punturieri A, Yana I, &, Weiss SJ, (2000) Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149, 1309-1323.
36. Hotary K, Li XY, Allen E, Stevens SL, &, Weiss SJ, (2006) A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 20, 2673-2686.
37. Gao G, Plaas A, Thompson VP, Jin S, Zuo F, &, Sandy JD, (2004) ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 279, 10042-10051.
38. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, &, Parks WC, (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137, 1445-1457.
39. 1 integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 276, 29368-29374.
40. Ellerbroek SM, Wu YI, Overall CM, &, Stack MS, (2001) Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276, 24833-24842.
41. Wolf K, Mazo I, Leung H, Engelke K, Von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, &, Friedl P, (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160, 267-277.
42. Gálvez BG, Matías-Román S, Yáñez- Mõ M, Sánchez-Madrid F, &, Arroyo AG, (2002) ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 159, 509-521.
43. Brooks PC, Strömblad S, Sanders LC, Von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, &, Cheresh DA, (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin avb3. Cell 85, 683-693.
44. Brooks PC, Silletti S, Von Schalscha TL, Friedlander M, &, Cheresh DA, (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400.
45. Petitclerc E, Strömblad S, Von Schalscha TL, Mitjans F, Piulats J, Montgomery AM, Cheresh DA, &, Brooks PC, (1999) Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 59, 2724-2730.
46. Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, &, Strongin AY, (2002) Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277, 9749-9756.
47. Gálvez BG, Matías-Román S, Albar JP, Sánchez-Madrid F, &, Arroyo AG, (2001) Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 276, 37491-37500.
48. Iida J, Wilhelmson KL, Ng J, Lee P, Morrison C, Tam E, Overall CM, &, McCarthy JB, (2007) Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J 403, 553-563.
49. Nisato RE, Hosseini G, Sirrenberg C, Butler GS, Crabbe T, Docherty AJ, Wiesner M, Murphy G, Overall CM, Goodman SL, et al. (2005) Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res 65, 9377-9387.
50. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, &, Nishimura SL, (2002) The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157, 493-507.
51. Shiomi T, Inoki I, Kataoka F, Ohtsuka T, Hashimoto G, Nemori R, &, Okada Y, (2005) Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab Invest 85, 1489-1506.
52. Yañez-Mõ M, Barreiro O, Gonzalo P, Batista A, Megías D, Genís L, Sachs N, Sala-Valdés M, Alonso MA, Montoya MC, et al. (2008) MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 112, 3217-3226.
53. Takino T, Miyamori H, Kawaguchi N, Uekita T, Seiki M, &, Sato H, (2003) Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem Biophys Res Commun 304, 160-166.
54. 3,8-10 is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176, 206-215.
55. Yu Q, &, Stamenkovic I, (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13, 35-48.
56. Lambert E, Bridoux L, Devy J, Dassé E, Sowa ML, Duca L, Hornebeck W, Martiny L, &, PetitfrÃire-Charpentier E, (2009) TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival. Int J Biochem Cell Biol 41, 1102-1115.
57. Redondo-Muñoz J, Ugarte-Berzal E, García-Marco JA, Del Cerro MH, Van den Steen PE, Opdenakker G, Terol MJ, &, García-Pardo A, (2008) Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood 112, 169-178.
58. Redondo-Muñoz J, Ugarte-Berzal E, Terol MJ, Van den Steen PE, Hernández del Cerro M, Roderfeld M, Roeb E, Opdenakker G, García-Marco JA, &, García-Pardo A, (2010) Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. Cancer Cell 17, 160-172.
59. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, &, Seiki M, (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153, 893-904.
60. Marrero-Diaz R, Bravo-Cordero JJ, Megías D, García MA, Bartolomé RA, Teixido J, &, Montoya MC, (2009) Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion. Cell Motil Cytoskeleton 66, 48-61.
61. Yu WH, &, Woessner JF Jr, (2000) Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7). J Biol Chem 275, 4183-4191.
62. Yu WH, Woessner JF Jr, McNeish JD, &, Stamenkovic I, (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16, 307-323.
63. Berton A, Selvais C, Lemoine P, Henriet P, Courtoy PJ, Marbaix E, &, Emonard H, (2007) Binding of matrilysin-1 to human epithelial cells promotes its activity. Cell Mol Life Sci 64, 610-620.
64. Koyama Y, Naruo H, Yoshitomi Y, Munesue S, Kiyono S, Kusano Y, Hashimoto K, Yokoi T, Nakanishi H, Shimizu S, et al. (2008) Matrix metalloproteinase-9 associated with heparan sulfate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells. J Biochem 143, 581-592.
65. Herz J, &, Strickland DK, (2001) LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108, 779-784.
66. Yang Z, Strickland DK, &, Bornstein P, (2001) Extracellular Matrix Metalloproteinase 2 levels are regulated by the Low DensityLlipoprotein-related scavenger receptor an thrombospondin 2. J Biol Chem 276, 8403-8408.
67. Emonard H, Belton G, Troeberg L, Berton A, Robinet A, Henriet P, Marbaix E, Kirkegaard K, Patthy L, Eeckhout Y, et al. (2004) Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J Biol Chem 279, 54944-54951.
68. Hahn-Dantona E, Ruiz JF, Bornstein P, &, Strickland DK, (2001) The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating Its Cellular Catabolism. J Biol Chem 276, 15498-15503.
69. Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lõpez-Otín C, Jeffrey JJ, &, Partridge NC, (1999) Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem 274, 30087-30093.
70. Troeberg L, Fushimi K, Khokha R, Emonard H, Ghosh P, &, Nagase H, (2008) Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 22, 3515-3524.
71. Van den Steen PE, Van Aelst I, Hvidberg V, Piccard H, Fiten P, Jacobsen C, Moestrup SK, Fry S, Royle L, Wormald MR, et al. (2006) The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J Biol Chem 281, 18626-18637.
72. Piccard H, Van den Steen PE, &, Opdenakker G, (2007) Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins. J Leukoc Biol 81, 870-892.
73. Monferran S, Paupert J, Dauvillier S, Salles B, &, Muller C, (2004) The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. Embo J 23, 3758-3768.
74. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, &, Nabeshima K, (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55, 434-439.
75. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, &, Kikuchi M, (2006) Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56, 359-367.
76. Guo HM, Li RS, Zucker S, &, Toole BP, (2000) EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 60, 888-891.
77. Noguchi Y, Sato T, Hirata M, Hara T, Ohama K, &, Ito A, (2003) Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro. J Clin Endocrinol Metab 88, 6063-6072.
78. Isacke CM, Van Der GP, Hunter T, &, Trowbridge IS, (1990) p180, a novel recycling transmembrane glycoprotein with restricted cell type expression. Mol Cell Biol 10, 2606-2618.
79. Wu K, Yuan J, &, Lasky LA, (1996) Characterization of a novel member of the macrophage mannose receptor type C lectin family. J Biol Chem 271, 21323-21330.
80. Behrendt N, Jensen ON, Engelholm LH, Mortz E, Mann M, &, Dano K, (2000) A urokinase receptor-associated protein with specific collagen binding properties. J Biol Chem 275, 1993-2002.
81. Leitinger B, &, Hohenester E, (2007) Mammalian collagen receptors. Matrix Biol 26, 146-155.
82. Lee H, Overall CM, McCulloch CA, &, Sodek J, (2006) A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 17, 4812-4826.
83. Messaritou G, East L, Roghi C, Isacke CM, &, Yarwood H, (2009) Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180. J Cell Sci 122, 4042-4048.
84. Yamamoto K, Higashi S, Kioi M, Tsunezumi J, Honke K, &, Miyazaki K, (2006) Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion. J Biol Chem 281, 9170-9180.
85. Higashi S, Oeda M, Yamamoto K, &, Miyazaki K, (2008) Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate. J Biol Chem 283, 35735-35744.
86. Xu X, Chen Z, Wang Y, Yamada Y, &, Steffensen B, (2005) Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2. Biochem J 392, 127-134.
87. Freise C, Erben U, Muche M, Farndale R, Zeitz M, Somasundaram R, &, Ruehl M, (2009) The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol 28, 480-489.
88. Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, &, Fridman R, (1998) High affinity binding of latent matrix metalloproteinase-9 to the a2(IV) chain of collagen IV. J Biol Chem 273, 10672-10681.
89. Owen CA, Hu Z, Barrick B, &, Shapiro SD, (2003) Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29, 283-294.
90. Bannikov GA, Karelina TV, Collier IE, Marmer BL, &, Goldberg GI, (2002) Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277, 16022-16027.
91. Jain A, Fisher LW, &, Fedarko NS, (2008) Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics. Biochemistry 47, 5986-5995.
92. Zhang L, Yang M, Yang D, Cavey G, Davidson P, &, Gibson G, (2010) Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins. Connect Tissue Res 51, 230-239.
93. Orgel JP, Irving TC, Miller A, &, Wess TJ, (2006) Microfibrillar structure of type I collagen in situ. Proc Natl Acad Sci USA 103, 9001-9005.
94. Perumal S, Antipova O, &, Orgel JP, (2008) Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci USA 105, 2824-2829.
95. Saffarian S, Collier IE, Marmer BL, Elson EL, &, Goldberg G, (2004) Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen. Science 306, 108-111.
96. Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, Chen S, Antipova O, Perumal S, Ala-Kokko L, et al. (2008) Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283, 21187-21197.
97. Gross J, &, Lapiere CM, (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48, 1014-1022.
98. Mauch S, Kolb C, Kolb B, Sadowski T, &, Sedlacek R, (2002) Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J Immunol 168, 1244-1251.
99. Overall CM, &, Blobel CP, (2007) In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8, 245-257.
100. Tomari T, Koshikawa N, Uematsu T, Shinkawa T, Hoshino D, Egawa N, Isobe T, &, Seiki M, (2009) High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells. Cancer Sci 100, 1284-1290.
101. Stricker TP, Dumin JA, Dickeson SK, Chung L, Nagase H, Parks WC, &, Santoro SA, (2001) Structural analysis of the alpha 2 Integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem 276, 29375-29381.
102. Patterson ML, Atkinson SJ, Knäuper V, &, Murphy G, (2001) Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 503, 158-162.
103. Stefanidakis M, Bjorklund M, Ihanus E, Gahmberg CG, &, Koivunen E, (2003) Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins. J Biol Chem 278, 34674-34684.
104. r active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci 99, 789-795.
105. Ra HJ, Harju-Baker S, Zhang F, Linhardt RJ, Wilson CL, &, Parks WC, (2009) Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans. J Biol Chem 284, 27924-27932.
106. Owen CA, Hu Z, Lõpez-Otín C, &, Shapiro SD, (2004) Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 172, 7791-7803.
107. Bjorklund M, Heikkila P, &, Koivunen E, (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279, 29589-29597.
108. Suenaga N, Mori H, Itoh Y, &, Seiki M, (2005) CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 24, 859-868.
109. Iida J, Pei D, Kang T, Simpson MA, Herlyn M, Furcht LT, &, McCarthy JB, (2001) Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J Biol Chem 276, 18786-18794.